Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Obeslim is an herbal dietary supplement developed by Ankh Pharmaceuticals, marketed for weight management and the support of individuals with obesity. It is part of a line of Ayurvedic-inspired consumer products that includes other branded supplements like Diabenon and Sanjeevini. As a multi-ingredient herbal formulation, Obeslim is positioned as a wellness product rather than a regulated pharmaceutical drug candidate. It does not have a single defined molecular target or standard clinical trial phases, and it is typically sold over-the-counter for general health maintenance and metabolic support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Obeslim.